文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症肝病学:定义、发病率、预后及肝衰竭在危重患者中的作用

Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients.
PubMed 文献 · Crit Care · 2022-09-26
一句话结论综述指出肝脏常是MODS的驱动者而非旁观者,传统转氨酶/胆红素难以反映代谢与免疫性肝功能障碍。

本文综述了ICU中肝功能障碍的定义、发病率、预后及肝衰竭在危重患者中的作用。器官功能障碍或衰竭在ICU患者中高达70%,结局取决于器官功能恢复;肝脏因免疫、调节和代谢功能参与多器官功能障碍综合征(MODS)。炎症反应失调、持续微循环(缺氧)损伤或药物性肝损伤可导致继发性肝衰竭(无基础肝病的获得性肝损伤)或慢加急性肝衰竭。传统实验室指标如转氨酶或胆红素对代谢和免疫性肝功能障碍的判断有限,且定义不统一导致发病率估计差异大。综述旨在统一对肝功能障碍作为MODS驱动因素和治疗靶点的理解。

要点

  • ICU患者器官功能障碍或衰竭发生率高达70%,结局取决于器官功能恢复。
  • 急性肝衰竭定义:无既往肝病、8周内出现肝性脑病的罕见可逆性严重肝损伤。
  • 继发性肝衰竭指无基础肝病的获得性肝损伤,或原有慢性肝病恶化(慢加急性肝衰竭)。
  • 炎症反应失调、持续微循环(缺氧)损伤或药物性肝损伤是继发性肝衰竭的主要问题。
  • 传统转氨酶或胆红素难以反映肝脏代谢和免疫功能的复杂障碍,且定义不统一使发病率估计差异大。

适用人群与场景

  • ICU危重患者,器官功能障碍或衰竭发生率高达70%。
  • 无既往肝病的获得性肝损伤患者(继发性肝衰竭)或原有慢性肝病恶化患者(慢加急性肝衰竭)。

诊断标准与关键阈值

  • 急性肝衰竭:无既往肝病,8周内出现肝性脑病的严重肝损伤。

研究设计与关键结果

  • 器官功能障碍或衰竭在ICU患者中高达70%,结局取决于器官功能恢复,未恢复器官的连锁恶化导致死亡率增加。
  • 肝脏因实质和非实质细胞的免疫、调节和代谢功能,在MODS中反映关键事件。
  • 炎症反应失调、持续微循环(缺氧)损伤或药物性肝损伤是继发性肝衰竭的主要问题。
  • 传统实验室标志物如转氨酶或胆红素对代谢和免疫性肝功能障碍的判断有限。
  • 定义不统一导致发病率估计差异大。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,应统一肝功能障碍的定义,以增进对肝功能障碍作为MODS驱动因素(及治疗靶点)的理解。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Organ dysfunction or overt failure is a commonplace event in the critically ill affecting up to 70% of patients during their stay in the ICU. The outcome depends on the resolution of impaired organ function, while a domino-like deterioration of organs other than the primarily affected ones paves the way for increased mortality. "Acute Liver Failure" was defined in the 1970s as a rare and potentially reversible severe liver injury in the absence of prior liver disease with hepatic encephalopathy occurring within 8 weeks. Dysfunction of the liver in general reflects a critical event in "Multiple Organ Dysfunction Syndrome" due to immunologic, regulatory and metabolic functions of liver parenchymal and non-parenchymal cells. Dysregulation of the inflammatory response, persistent microcirculatory (hypoxic) impairment or drug-induced liver injury are leading problems that result in "secondary liver failure," i.e., acquired liver injury without underlying liver disease or deterioration of preexisting (chronic) liver disease ("Acute-on-Chronic Liver Failure"). Conventional laboratory markers, such as transaminases or bilirubin, are limited to provide insight into the complex facets of metabolic and immunologic liver dysfunction. Furthermore, inhomogeneous definitions of these entities lead to widely ranging estimates of incidence. In the present work, we review the different definitions to improve the understanding of liver dysfunction as a perpetrator (and therapeutic target) of multiple organ dysfunction syndrome in critical care.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Perez Ruiz de Garibay A, Kortgen A, Leonhardt J, et al. Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients. Crit Care. 2022. PMID: 36163253. doi:10.1186/s13054-022-04163-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。